Ketamine

This article was originally published on Psychedelic Spotlight and appears here with permission. For the most part, psychedelics are still illegal in Mexico with a few exceptions. As Mexico’s lawmakers continue to express their interest in legalizing magic mushrooms, more questions about...

In this episode of The Dales Report, we’re sitting down with Numinus Wellness CEO Payton Nyquvest for a psychedelic exclusive. Our topic of conversation with Payton today steers into the recent FDA warning and the dynamic world of off-label markets for new compounds. First up: The FDA made...

Awakn Life Sciences Corp. (OTC: AWKNF), a biotech firm focused on developing therapies for addiction, with a primary emphasis on Alcohol Use Disorder (AUD), has taken a big step toward Phase III clinical trial initiation today. The company has submitted a Clinical Trial Application...

Psycheceutical Bioscience, Inc (OTCPK: BWVI) is a cutting-edge biotech startup that developed a topical drug delivery system called NeuroDirect, a system that can be used to deliver psychedelic drugs directly to the brain, avoiding the traditional “high” and side effects. The...

The ongoing use of ketamine by Tesla chief Elon Musk may be causing his unpredictable behavior, suggests journalist Ronan Farrow, WION reported. In a recent CNN interview, Farrow, who recently wrote an extensive piece on Musk in the New Yorker, indicated that Musk’s ketamine...

This article was originally published on Microdose and appears here with permission. With MAPS moving its historic Phase 3 MDMA trial towards FDA approval, the movement toward psychedelic legalization is gaining increasing momentum. The forthcoming FDA approval of MDMA will be a milestone...

On this new Psychedelics Exclusive podcast, TDR Founder Shadd Dales interviews Awakn Life Sciences Corp. (OTC: AWKNF) CEO Anthony Tennyson, as his company moves closer towards a Phase III clinical trial exploring the use of ketamine-assisted therapy to treat severe Alcohol Use...

A newly published study shows that Kernel’s Flow technology system is in fact able to capture and analyze brain changes following the administration of a psychoactive substance. Published in the Nature Journal Scientific Reports and sponsored by psychedelics firm Cybin (NYSE: CYBN), the...

Global pharmaceutical behemoth Johnson & Johnson (NYSE: JNJ) today announced results for their fiscal second quarter 2023. The company handily surpassed analyst forecasts by reporting adjusted earnings per share of $2.80 versus the consensus $2.62, and raised full year...

In a trend that’s raising eyebrows and questions about corporate responsibility, Silicon Valley executives, including Elon Musk and Sergey Brin, are increasingly turning to psychedelics such as ketamine, LSD, and magic mushrooms for business insights and personal growth, The Wall Street...

In just a few weeks, on the evening of Tuesday, June 20th, Denver, Colorado, will play host to a remarkable event aimed at shedding light on a significant group of heroes: women veterans. The dinner, set to take place from 7:00 PM to 10:30 PM at the local hotspot, Bang Up To The Elephant, is much...

Specialty pharmaceutical company PharmaTher Holdings (OTCQB: PHRRF) has submitted a Fast Track Application to the Food and Drug Administration (FDA) for KETARX, a ketamine drug that may help treat levodopa-induced dyskinesia in Parkinson’s disease. Fast Track designation is for...

The future of ketamine telehealth clinics, the number of which grew during the Covid-19 pandemic, is uncertain due to new rules from the Drug Enforcement Administration (DEA). The rules, which aim to undo controlled substances prescribed via telehealth, have received over 21,000 public comments,...

Specialty ketamine company PharmaTher Holdings Ltd. (OTCQB: PHRRF) submitted its Type B meeting package to the FDA to discuss the remaining requirements for the KETARX on-body pump system and submit the corresponding New Drug Application (NDA) under the 505(b)(2) pathway by the end of 2023. See...

This article was originally published on Psychedelic Spotlight and appears here with permission.  It is understandable that people are apprehensive about ketamine use considering its well-known misuse. However, when administered under the direction of a medical professional for depression or...